Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The two screenshots show the same Study Details page for NCT02118337 with identical content and layout. No substantive differences are detected.
    Difference
    0.3%
    Check dated 2025-11-03T13:05:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    - Added a government funding/operating status notice and current NIH Clinical Center information; updated version to v3.2.0. - Removed reference to v3.1.0.
    Difference
    1%
    Check dated 2025-10-05T17:41:58.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Content update: terminology refined from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a new version tag v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T11:12:34.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:39:42.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T21:27:54.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, as well as specific resources related to clear cell renal carcinoma and kidney cancer. Additionally, several medical terms and proteins have been added, while some previous terms and locations have been removed.
    Difference
    3%
    Check dated 2025-08-30T16:03:41.000Z thumbnail image

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.